Cresco Labs Inc. (CSE: CL)

Market Cap	581.17M
Revenue (ttm)	981.27M
Net Income (ttm)	-91.10M
Shares Out	348.00M
EPS (ttm)	-0.27
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	104,527
Open	1.640
Previous Close	1.690
Day's Range	1.610 - 1.830
52-Week Range	1.410 - 3.580
Beta	1.97
Analysts	n/a
Price Target	n/a
Earnings Date	Nov 11, 2024

About Cresco Labs

Cresco Labs Inc., together with its subsidiaries, cultivates, manufactures, and sells retail and medical cannabis products in the United States. It provides cannabis in flowers, vape pens, live resins, disposable pens, and extracts under the Cresco brand; vape carts, vape pens, flower, popcorn, shake, pre-rolls, shorties, and concentrates under the High Supply brand; vapes and gummies under the Good News brand; vapes and edibles under the Wonder Wellness Co. brand; and tinctures, capsules, salves, and sublingual oils under the Remedi brand. The...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1990
• Employees: 2,760
• Stock Exchange: Canadian Securities Exchange
• Ticker Symbol: CL

Financial Performance

In 2023, Cresco Labs's revenue was $756.06 million, a decrease of -8.35% compared to the previous year's $824.93 million. Losses were -$175.52 million, -17.22% less than in 2022.

Financial numbers in USD